Abstract:
An expression inhibitor of VCAM and COX-2 in inflammation disease is provided to offer an anti-inflammation material including GAGs as an active ingredient and to reduce oncogenesis by providing the basic particle mechanism about anti-inflammation effect. An expression inhibitor of VCAM and COX-2 in inflammation disease comprises glycosaminoglycans extracted from the skin of styela clava or sea squirt as an active ingredient. The glycosaminoglycan is chondroitin sulfate and suppresses the activity of the NF- kappa B (nuclear factor kappaB).
Abstract:
A use of fish feed containing carotenoid, highly unsaturated fatty acid and conjugated linoleic acid as an active ingredient is provided to ensure improvement in the growth of fish and oxidation stability of fish meat while converting conjugated linoleic acid to lipid components of fish when fed to fish. Fish feed containing fish meal, soybean meal, wheat flour, cuttlefish liver oil, vitamin, mineral and soybean oil is characterized in that it contains 0.5% by weight of carotenoid selected from natural carotenoid and synthetic carotenoid, 5 to 25% by weight of highly unsaturated fatty acid and 1 to 5% by weight of conjugated linoleic acid, based on the total weight of the fish feed. The fish feed overcomes the problems of inhibiting the growth of fish when a quantity of conjugated linoleic acid is fed to fish and improves meat quality by accumulation of carotenoid pigments when fed to fish.
Abstract:
본 발명은 생체 분석 물질을 빠르게 추적(tracking), 표적(targeting) 및 형상(imaging) 하는데 이용할 수 있는 형광 표면증강 라만 산란 나노-표지 입자 및 이의 제조방법에 관한 것이다. 본 발명에 따른 형광 표면증강 라만 산란 나노-표지 입자는 형광 및 라만 산란에 매우 민감하기 때문에 생체 분석 물질을 보다 쉽고, 빠르게 분석할 수 있다. 따라서, 본 발명에 따른 형광 표면증강 라만 산란 나노-표지 입자는 세포와 조직에서 암 또는 다른 질병과 관련된 다양한 세포학적 및 분자학적 현상의 분석에 쉽게 이용될 수 있다. 라만, 형광, 나노-표지입자, 아포프토시스
Abstract:
The present invention relates to a fluorescent dye-labeled glucose analog, and a synthesis method and usage of the same, and more particularly, to novel glucose α and &bgr; anomers in which a fluorescent dye is labeled by O-1-glycosylation, an asymmetric synthesis method of the anomers, a molecular bioimaging method of the anomers, and a screening method of curing or preventing drugs for diseases related to glucose metabolism.
Abstract:
A novel viral gene carrier is provided to deliver a gene specifically to tumor cells by controlling the gene delivery efficiency with low cytotoxicity and high stability and having higher transduction efficiency to a receptor positive KB cell. A viral gene carrier is characterized in that it is prepared by modifying the surface of a recombinant baculovirus vector including a green fluorescent protein, luciferase or a PDCD4 (programmed cell death 4) gene using a folate-polyethylene glcyol conjugate. A method for preparing the viral gene carrier comprises the steps of: (a) preparing the recombinant baculovirus vector; (b) preparing the folate-polyethylene glycol conjugate; and (c) modifying the recombinant baculovirus vector surface with the folate-polyethylene glycol conjugate.
Abstract:
본 발명은 라만 산란과 광산란(Light Scattering) 검출 시스템에 관한 것으로, 특히 라만 산란과 동적 광산란(Dynamic Light Scattering)의 동시 검출 장치 및 방법에 관한 것이다. 본 발명은 라만 산란과 동적 광산란의 동시 검출 장치로서, 라만 산란과 광산란의 동시 검출는 입사광을 시료에 입사하고 라만 산란과 광산란을 동시에 수집하기 위한 180° 구조의 라만 산란 측정 및 90° 구조의 광산란 측정을 이용한 검출수단; 및 상기 산란광 검출 수단과 연결되어 자기상관함수를 연산하여 입자의 크기 및 분포를 측정하고, 분자 구조를 측정하기 위한 컴퓨터를 포함한다. 이 장치는 나노 크기 이상의 물질의 크기와 이를 이루는 분자적 정보를 동시에 관찰할 수 있고 물질의 변화에 따른 분자적 환경의 변화와 그 크기 및 분포의 변화를 동반하는 현상을 관찰할 수 있어 나노 물질 및 단백질 항원-항체 관련 연구에 매우 유용하다. 라만 산란, 동적 광산란, 분광계, 동시측정
Abstract:
A simultaneous detection apparatus of Raman and light scattering is provided to analyze information on nano material and its molecules by simultaneously detecting Raman scattering and light scattering of one sample. A simultaneous detection apparatus of Raman and light scattering includes a laser generator(110), a Raman scattering detector(120), a dynamic light scattering detector, a spectrometer(140), and a computer(150). The laser generator generates a laser beam of 514.5nm Ar-ion as incident light. The incident light passes through a light condensing lens(112) and is reflected from a plane mirror(111) to enter the Raman scattering detector. The Raman scattering detector has a notch filter(121), an objective lens(123), and a first collecting lens(125). When the light reflected from the plane mirror enters a sample, the light is scattered while some of the light is collected again by the objective lens. Raman scattering light is transmitted to the spectrometer by the first collecting lens. The spectrometer detects the spectrum of the Raman scattering light. The dynamic light scattering detector, arranged at an angle of 90 degrees with respect to the incident light, has a second collecting lens(131), an iris(132), and a PMT(Photomultiplier Tube) detector(133). The computer is connected to the dynamic light scattering detectors, performs an autocorrelation function to measure the size and distribution of particles, and measures molecular structure.
Abstract:
PURPOSE: A poly(ester amine)/DNA complex for non-viral DNA carrier is provided to ensure poly(ester amine)-controlled resolution, low cytotoxin, and high transfection efficiency, to be useful as an effective polymer carrier, and to exhibit big potential in intercellular gene transfer. CONSTITUTION: A method for manufacturing a poly(ester amine) polymer comprises the steps of: respectively dissolving glyceroldimethylacrylate or glyceroltrimethylacrylate and low molecular polyethylenimine (molecular weight 200-3,000) in methanol anhydride and then adding a glycerol dimethylacrylate solution to a polyethylenimine solution and mixing them; stirring and heating the mixed solution at 50-70 °C for 12-36 hours; dialyzing the mixture for 2-5 hours to 12-36 hours; and then lyophilizing the obtained polymer.
Abstract:
본 발명은 네오스포라 캐니늄 감염증 예방 및 치료용 조성물에 관한 것이다. 본 발명에 따른 고삼 또는 사상자 추출물 또는 이의 분획물을 포함하는 약학적 조성물은 N. 캐니늄 감염증을 예방 또는 치료하는데 매우 유용하다. 구체적으로 본 발명의 약학적 조성물은 마우스에서 N. 캐니늄 감염을 방어할 수 있으며 임신 염소에 있어서는 유산 발생율을 경감시킬 수 있다. 네오스포라 캐니늄, 고삼, 사상자
Abstract:
A composition for treatment of breast cancer is provided to investigate anti-cancer capability and mechanism in MCF-7 breast cancer cell using alpha-eleostearic acid. A composition for treatment of breast cancer includes alpha-eleostearic acid to active ingredient. A remedial method of disease at cancer cell line includes a step of processing the alpha-eleostearic acid of a therapeutically effective amount to the cancer cell line and prevents, suppresses or improves pathology or symptom of diseases by adjustment of PPAR gamma activity or phosphorylation of ERK1/2.